|
End-of-day quote
Buenos Aires S.E.
30/09/2026
|
5-day change | 1st Jan Change | ||
| 149.00 ARS | +2.41% |
|
-3.25% | -38.05% |
| Market Cap | 6.35B 4.16M 3.67M 3.48M 3.14M 5.93M 399M 5.99M 41.65M 16.02M 204M 15.63M 15.29M 655M | P/E 2024 |
-3.67x | P/E 2025 | -2.23x |
|---|---|---|---|---|---|
| Enterprise Value | 7.08B 4.65M 4.1M 3.88M 3.51M 6.62M 445M 6.69M 46.49M 17.88M 228M 17.45M 17.06M 731M | EV / Sales 2024 |
0.73x | EV / Sales 2025 | 1.71x |
| Free-Float |
19.84% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +2.41% | ||
| 1 week | -3.25% | ||
| Current month | -8.02% | ||
| 1 month | -8.02% | ||
| 3 months | -9.15% | ||
| 6 months | +9.96% | ||
| Current year | -38.05% |
| 1 week | 142 | 150.5 | |
| 1 month | 142 | 165 | |
| Current year | 128.5 | 260 | |
| 1 year | 116 | 357 | |
| 3 years | 35 | 450 | |
| 5 years | 9.1 | 450 | |
| 10 years | 4.2 | 450 |
| Manager | Title | Age | Since |
|---|---|---|---|
Oscar Echeverria
DFI | Director of Finance/CFO | - | 30/07/2010 |
Federico Hoffman
CTO | Chief Tech/Sci/R&D Officer | - | - |
Eduardo Busto
ADM | Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 30/07/2010 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.41% | -3.25% | +12.45% | +313.31% | 4.06M | ||
| -2.33% | -1.12% | +59.27% | +115.42% | 1,056B | ||
| -1.06% | -1.65% | +45.77% | +69.98% | 645B | ||
| -0.65% | -1.36% | +17.22% | +75.49% | 465B | ||
| -2.66% | -3.71% | +84.92% | +41.15% | 368B | ||
| -0.06% | -4.12% | +36.31% | +39.39% | 335B | ||
| -0.79% | +3.01% | +21.11% | +27.79% | 275B | ||
| -1.19% | -3.09% | +10.75% | +10.61% | 255B | ||
| -0.50% | +2.75% | +53.85% | +56.84% | 229B | ||
| -1.47% | -2.37% | +32.35% | +98.89% | 188B | ||
| Average | +0.09% | +0.14% | +37.40% | +84.89% | 381.58B | |
| Weighted average by Cap. | +0.34% | +0.30% | +44.68% | +71.39% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 8.27B 5.43M 4.79M 4.53M 4.1M 7.73M 520M 7.81M 54.31M 20.89M 266M 20.38M 19.93M 854M | 6.4B 4.2M 3.71M 3.51M 3.17M 5.98M 402M 6.04M 42.03M 16.16M 206M 15.77M 15.43M 661M |
| Net income | -1.42B -930K -821K -777K -702K -1.32M -89.08M -1.34M -9.3M -3.58M -45.64M -3.49M -3.41M -146M | -4.6B -3.02M -2.66M -2.52M -2.28M -4.29M -289M -4.34M -30.17M -11.6M -148M -11.32M -11.08M -475M |
| Net Debt | 863M 566K 500K 473K 427K 806K 54.25M 815K 5.67M 2.18M 27.8M 2.13M 2.08M 89.13M | 738M 484K 427K 404K 365K 689K 46.37M 696K 4.84M 1.86M 23.76M 1.82M 1.78M 76.18M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/09/26 | ARS 149.00 | +2.41% | 11,382 |
| 29/09/26 | ARS 145.50 | -1.69% | 11,660 |
| 28/09/26 | ARS 148.00 | +0.68% | 6,385 |
| 25/09/26 | ARS 147.00 | -1.01% | 2,624 |
| 24/09/26 | ARS 148.50 | -3.88% | 3,840 |
- Stock Market
- Stocks
- ROSE Stock
Select your edition
All financial news and data tailored to specific country editions
















